Middle East And Africa Molecular Weight Marker Market

Middle East And Africa Molecular Weight Marker Market Size (2023 to 2028)

Middle East and Africa Molecular weight Marker market is anticipated to grow at 10.394% CAGR from 2023 to 2028 and it is estimated that the Middle East and Africa market was valued at USD 29.52 million in 2023 and is expected to reach USD 48.40 million by 2028.

A molecular-weight size marker, also known as a protein ladder, DNA ladder, or RNA ladder, is a set of standards that are used to identify the approximate size of a molecule run on a gel during electrophoresis, utilizing the principle that molecular weight is inversely proportional to migration rate through a gel matrix.

An increase in the popularity of personalized medicines for the treatment of chronic diseases and genetic disorders is a major factor contributing toward the growth of the market. Personalized medicines involve the application of molecular weight markers for the study of individual’s genome, genes, and diseases. Thus, growing adoption of personalized medicines along with the escalating focus on molecular biology research is expected to boost the demand for molecular weight marker products. Technological advancement in molecular biology products, such as PCR and NGS coupled with high-quality molecular weight marker is another major factor contributing toward growth. Advancement in recent times in these products has provided provision for a clearer background and sharp bands. Thus, the demand for molecular weight marker products is expected to grow in the near future, which in turn is expected to boost the market growth.

 The Middle East and Africa Molecular weight Marker market is segmented on the basis of Products, Type, End User, and Application. On the basis of product, it is segmented into DNA, RNA, and Protein Ladders. The DNA markers segment was the largest revenue-grossing segment and is projected to grow at significant CAGR during the forecast period. Rising R&D activities related to genomics research boosts the demand for DNA markers for genome mapping. The protein markers segment is expected to witness a lucrative growth during the forecast period, owing to the rise in the application of these products for proteomics study. The researchers and biotechnology companies are focusing on the application of proteomics study for new drug discovery and clinical diagnostics. On the basis of Type, it is segmented into Pre-stained, and Specialty. Pre-stained markers were the highest revenue-generating segment in, due to their large application in genomics and proteomics research. The unstained segment is estimated to witness significant growth in the coming years due to its ability to provide highly accurate molecular weight determinations of the sample over a wide molecular weight range. On the basis of Application, it is segmented into PCR, Western Blotting, and Gel Extraction. Molecular weight marker has applications in nucleic acid and proteomics study. The nucleic acid segment dominated the sector is due to an increasing focus on DNA- and RNA-based research. The growing demand for advanced diagnostics and therapeutics products has led to an increased focus on genomics research. The proteomics application segment is expected to be the fastest-growing segment. Rising application of western blotting and gel extraction for proteomics research including drug discovery and clinical diagnostics drives the growth of the market. On the basis of End User, the market is segmented into Contact Research Organizations (CRO), Pharmaceutical Companies, and Academic Institutes. The academic and research institutes segment accounted for the largest share in terms of revenue due to rising funding for molecular biology research by private and government organizations. There is a growing focus on research based on genomics such as genotyping, cytogenetics, gene expression, epigenetic analysis, and transcriptome analysis, which is boosting the application of molecular weight markers in academic and research institutes. The pharmaceutical and biotechnology companies segment is anticipated to witness significant CAGR over the forecast period due to the rising investment in R&D for new drug development.

On the basis of geography, the market I segmented into various regions namely Middle East and Africa. MEA is expected to witness significant growth due to the rising focus of CROs and biotechnology companies in this region for drug discovery and development.

Some of the key players dominating the market are F Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies, Sigma-Aldrich, Affymetrix, Inc., QIAGEN, Takara Bio Inc., Bio-Rad Laboratories, Promega Corporation and New England Biolabs.